Reduced incidence of ischemic stroke in patients with severe factor XI deficiency

被引:273
作者
Salomon, Ophira [1 ]
Steinberg, David M. [2 ]
Koren-Morag, Nita [3 ]
Tanne, David [3 ,4 ]
Seligsohn, Uri [1 ]
机构
[1] Tel Aviv Univ, Tel Hashomer & Sackler Fac Med, Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Div Epidemiol, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Sheba Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1182/blood-2007-10-120139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inherited disorders of hemostasis are natural models for investigating mechanisms of thrombosis and development of antithrombotic therapy. Because mice with total factor XI deficiency are protected against ischemic stroke and do not manifest excessive bleeding, we investigated the incidence of ischemic stroke in patients with severe inherited factor XI deficiency. Incidence of ischemic stroke in 115 patients aged 45 years or more with severe factor XI deficiency (activity less than 15 U/dL) was compared with incidence in the Israeli population as estimated from a stroke survey of 1528 patients. Adjustment for major risk factors of stroke (hypertension, diabetes mellitus, hypercholesterolemia, current smoking) was based on comparison of their prevalence in the stroke survey to an Israeli health survey of 9509 subjects. Incidence of myocardial infarction in the factor XI cohort was also recorded. After adjustment for the 4 major risk factors of ischemic stroke, the expected incidence of ischemic stroke was 8.56 compared with one observed (P =.003). The reduced 1:115 incidence of ischemic stroke contrasted with a 19:115 incidence of myocardial infarction, similar to the expected incidence. Thus, severe factor XI deficiency probably is protective against ischernic stroke but not against acute myocardial infarction.
引用
收藏
页码:4113 / 4117
页数:5
相关论文
共 40 条
[1]   Vascular bed-specific thrombosis [J].
Aird, W. C. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 :283-291
[2]   FACTOR-XI (PLASMA THROMBOPLASTIN ANTECEDENT) DEFICIENCY IN ASHKENAZI JEWS IS A BLEEDING DISORDER THAT CAN RESULT FROM 3 TYPES OF POINT MUTATIONS - (COAGULATION GENETIC-DEFECT POLYMERASE CHAIN-REACTION) [J].
ASAKAI, R ;
CHUNG, DW ;
RATNOFF, OD ;
DAVIE, EW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7667-7671
[3]   FACTOR-XI DEFICIENCY IN ASHKENAZI JEWS IN ISRAEL [J].
ASAKAI, R ;
CHUNG, DW ;
DAVIE, EW ;
SELIGSOHN, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :153-158
[4]   Amyloid β-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells [J].
Davis, J ;
Wagner, MR ;
Zhang, WB ;
Xu, F ;
Van Nostrand, WE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (21) :19054-19061
[5]  
Fried Linda P., 1991, Annals of Epidemiology, V1, P263
[6]  
GREEN MS, 2006, ISRAEL NATL HLTH INT
[7]   Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates [J].
Gruber, A ;
Hanson, SR .
BLOOD, 2003, 102 (03) :953-955
[8]  
JORDE J, 1992, GENETIC DIVERSITY JE, P304
[9]   Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis [J].
Kleinschnitz, C ;
Stoll, G ;
Bendszus, M ;
Schuh, K ;
Pauer, HU ;
Burfeind, P ;
Renné, C ;
Gailani, D ;
Nieswandt, B ;
Renné, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (03) :513-518
[10]   Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation [J].
Ladenvall, Claes ;
Gils, Ann ;
Jood, Katarina ;
Blomstrand, Christian ;
Declerck, Paul J. ;
Jern, Christina .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (04) :955-962